Added to YB: 2024-10-18
Pitch date: 2024-10-18
KZR [bullish]
Kezar Life Sciences, Inc.
-5.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.
Market Cap
$65.3M
Pitch Price
$0.86
Price Target
2.03 (+149%)
Dividend
N/A
Sector
Biotechnology
Category
value
Kezar Life Sciences (KZR) Trades at Discount to Cash Value, Rejects $1.10 Buyout Offer
KZR: Biotech net/net at 82c/sh with $148M cash ($2.03/sh), $1.84/sh TBV. Board rejected Tang's $1.10/sh + CVR offer, implemented poison pill. Special situation with potential upside given cash position vs. current price.
Read full article (1 min)